Fifth Third Wealth Advisors LLC Acquires 1,675 Shares of Kenvue Inc. $KVUE

Fifth Third Wealth Advisors LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 3.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 45,212 shares of the company’s stock after buying an additional 1,675 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in Kenvue were worth $946,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in KVUE. Vanguard Group Inc. grew its holdings in shares of Kenvue by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock valued at $5,494,882,000 after purchasing an additional 10,600,682 shares during the last quarter. Third Point LLC bought a new stake in Kenvue in the 1st quarter worth $213,422,000. Maverick Capital Ltd. bought a new stake in Kenvue in the 1st quarter worth $203,036,000. Nuveen LLC bought a new stake in Kenvue in the 1st quarter worth $187,123,000. Finally, Voya Investment Management LLC grew its holdings in Kenvue by 131.3% in the 1st quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company’s stock worth $290,557,000 after acquiring an additional 6,886,784 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of a number of recent analyst reports. The Goldman Sachs Group cut their price target on shares of Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Thursday, October 2nd. UBS Group cut their price target on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday. Rothschild & Co Redburn raised shares of Kenvue from a “neutral” rating to a “buy” rating and cut their price target for the stock from $22.50 to $22.00 in a report on Friday, September 26th. JPMorgan Chase & Co. dropped their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Rothschild Redb raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $21.18.

Kenvue Trading Down 1.0%

NYSE:KVUE opened at $16.68 on Friday. The company has a 50-day moving average price of $19.15 and a 200-day moving average price of $21.32. Kenvue Inc. has a 12 month low of $15.47 and a 12 month high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The stock has a market cap of $32.00 billion, a price-to-earnings ratio of 22.53, a P/E/G ratio of 2.39 and a beta of 0.72.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same period last year, the company posted $0.32 EPS. Kenvue’s revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This is an increase from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a yield of 5.0%. Kenvue’s dividend payout ratio is 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.